SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 26.37-8.4%Jan 16 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cacaito who wrote (10016)5/17/1999 12:03:00 AM
From: PrometheusTex  Read Replies (1) of 17367
 
Wow...thanks for the complete response C...

It will take some time to go through all your references. Thanks for the lesson; I need to catch up again. Your references for the lack of change in mortality were appreciated; however, aren't these all examples following the achievement of some marker event. My impression was that the extreme aggression of the critical care docs toward meningio., as well as early recognition, had changed over the last ten years, and that it was this aggression that prevented kids from progressing to/through the markers of impending mortality. Kind of heading off the disease before it got out of hand. If this has not been borne out in the literature, I might have to abandon this notion.

Again, thanks; perhaps we will meet on the ALLP group too.

ProTex
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext